KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK

Cellular Signalling

Volumn 28, Issue 3, 2016, Pages 165-176

  Goertzen, Cameron G ^a   Dragan, Magdalena ^a   Turley, Eva ^a,c   Babwah, Andy V ^a,b,d   Bhattacharya, Moshmi ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c The Children's Health Research Institute ^*  (Canada)

^d CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Invadopodia; Invasion; KISS1R; Kisspeptin; Triple negative breast cancer; Arrestin

Indexed keywords

BETA ARRESTIN 2; COFILIN; CORTACTIN; G PROTEIN COUPLED RECEPTOR 54; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ARRB2 PROTEIN, HUMAN; BETA ARRESTIN; COFILIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; KISS1R PROTEIN, HUMAN; NITRILE; RETINA S ANTIGEN; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL COMPONENT; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PODOSOME; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL MOTION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE;

ARRESTINS; BETA-ARRESTIN 2; BETA-ARRESTINS; BREAST NEOPLASMS; BUTADIENES; CELL LINE, TUMOR; CELL MOVEMENT; COFILIN 1; CORTACTIN; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 14; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; PODOSOMES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84956731722     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.12.010     Document Type: Article

References (53)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. CA Cancer J. Clin. 2011, 61(2):69-90.
2. Carey L., Winer E., Viale G., Cameron D., Gianni L. Nat. Rev. Clin. Oncol. 2010, 7(12):683-692.
3. Lappano R., Maggiolini M. Nat. Rev. Drug Discov. 2011, 10(1):47-60.
4. Kirby H.R., Maguire J.J., Colledge W.H., Davenport A.P. Pharmacol. Rev. 2010, 62(4):565-578.
5. Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J.M., Le Poul E., Brezillon S., Tyldesley R., Suarez-Huerta N., Vandeput F., Blanpain C., Schiffmann S.N., Vassart G., Parmentier M. J. Biol. Chem. 2001, 276(37):34631-34636.
6. Takino T., Koshikawa N., Miyamori H., Tanaka M., Sasaki T., Okada Y., Seiki M., Sato H. Oncogene 2003, 22(30):4617-4626.
7. Harihar S., Pounds K.M., Iwakuma T., Seidah N.G., Welch D.R. PLoS One 2014, 9(1).
8. Lee J.H., Miele M.E., Hicks D.J., Phillips K.K., Trent J.M., Weissman B.E., Welch D.R. J. Natl. Cancer Inst. 1996, 88(23):1731-1737.
9. Sanchez-Carbayo M., Capodieci P., Cordon-Cardo C. Am. J. Pathol. 2003, 162(2):609-617.
10. Jiang Y., Berk M., Singh L.S., Tan H., Yin L., Powell C.T., Xu Y. Clin. Exp. Metastasis 2005, 22(5):369-376.
11. Sun Y.B., Xu S. Int. J. Oncol. 2013, 43(2):521-530.
12. Makri A., Pissimissis N., Lembessis P., Polychronakos C., Koutsilieris M. Cancer Treat. Rev. 2008, 34(8):682-692.
13. Cvetkovic D., Dragan M., Leith S.J., Mir Z.M., Leong H.S., Pampillo M., Babwah A.V., Bhattacharya M. Endocrinology 2013, 154(6):1999-2014.
14. Martin T.A., Watkins G., Jiang W.G. Clin. Exp. Metastasis 2005, 22(6):503-511.
15. Marot D., Bieche I., Aumas C., Esselin S., Bouquet C., Vacher S., Lazennec G., Perricaudet M., Kuttenn F., Lidereau R., de Roux N. Endocr. Relat. Cancer 2007, 14(3):691-702.
16. Cho S.G., Wang Y., Rodriguez M., Tan K., Zhang W., Luo J., Li D., Liu M. Cancer Res. 2011, 71(20):6535-6546.
17. Cvetkovic D., Babwah A.V., Bhattacharya M. J. Cancer 2013, 4(8):653-661.
18. Zajac M., Law J., Cvetkovic D.D., Pampillo M., McColl L., Pape C., Di Guglielmo G.M., Postovit L.M., Babwah A.V., Bhattacharya M. PLoS One 2011, 6(6).
19. Yamaguchi H. Eur. J. Cell Biol. 2012, 91(11-12):902-907.
20. Jiang W.G., Davies G., Martin T.A., Parr C., Watkins G., Mason M.D., Mansel R.E. Int. J. Mol. Med. 2006, 17(4):583-590.
21. Li T.T., Alemayehu M., Aziziyeh A.I., Pape C., Pampillo M., Postovit L.M., Mills G.B., Babwah A.V., Bhattacharya M. Mol. Cancer Res. 2009, 7(7):1064-1077.
22. Alemayehu M., Dragan M., Pape C., Siddiqui I., Sacks D.B., Di Guglielmo G.M., Babwah A.V., Bhattacharya M. PLoS One 2013, 8(2).
23. Schlienger S., Campbell S., Claing A. Mol. Biol. Cell 2014, 25(1):17-29.
24. Mader C.C., Oser M., Magalhaes M.A., Bravo-Cordero J.J., Condeelis J., Koleske A.J., Gil-Henn H. Cancer Res. 2011, 71(5):1730-1741.
25. Oser M., Yamaguchi H., Mader C.C., Bravo-Cordero J.J., Arias M., Chen X., Desmarais V., van Rheenen J., Koleske A.J., Condeelis J. J. Cell Biol. 2009, 186(4):571-587.
26. Fukazawa H., Noguchi K., Murakami Y., Uehara Y. Mol. Cancer Ther. 2002, 1(5):303-309.
27. Balzer E.M., Whipple R.A., Thompson K., Boggs A.E., Slovic J., Cho E.H., Matrone M.A., Yoneda T., Mueller S.C., Martin S.S. Oncogene 2010, 29(48):6402-6408.
28. Lauzier A., Charbonneau M., Harper K., Jilaveanu-Pelmus M., Dubois C.M. Arthritis Rheum. 2011, 63(6):1591-1602.
29. Allan A.L., George R., Vantyghem S.A., Lee M.W., Hodgson N.C., Engel C.J., Holliday R.L., Girvan D.P., Scott L.A., Postenka C.O., Al-Katib W., Stitt L.W., Uede T., Chambers A.F., Tuck A.B. Am. J. Pathol. 2006, 169(1):233-246.
30. Gilhooly E.M., Rose D.P. Int. J. Oncol. 1999, 15(2):267-270.
31. Lee G.Y., Kenny P.A., Lee E.H., Bissell M.J. Nat. Methods 2007, 4(4):359-365.
32. Cao R., Chen J., Zhang X., Zhai Y., Qing X., Xing W., Zhang L., Malik Y.S., Yu H., Zhu X. Br. J. Cancer 2014, 111(3):539-550.
33. Martinez-Quiles N., Ho H.Y., Kirschner M.W., Ramesh N., Geha R.S. Mol. Cell. Biol. 2004, 24(12):5269-5280.
34. Blangy A., Touaitahuata H., Cres G., Pawlak G. PLoS One 2012, 7(9).
35. Nyalendo C., Sartelet H., Gingras D., Beliveau R. Anticancer Res. 2010, 30(6):1887-1895.
36. Nyalendo C., Michaud M., Beaulieu E., Roghi C., Murphy G., Gingras D., Beliveau R. J. Biol. Chem. 2007, 282(21):15690-15699.
37. Nyalendo C., Beaulieu E., Sartelet H., Michaud M., Fontaine N., Gingras D., Beliveau R. Carcinogenesis 2008, 29(8):1655-1664.
38. Tague S.E., Muralidharan V., D'Souza-Schorey C. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(26):9671-9676.
39. Zhang Z., Song T., Jin Y., Pan J., Zhang L., Wang L., Li P. Int. J. Gynecol. Cancer 2009, 19(6):998-1003.
40. Williams K.C., Coppolino M.G. J. Biol. Chem. 2011, 286(50):43405-43416.
41. Nebl G., Fischer S., Penzel R., Samstag Y. Cell. Signal. 2004, 16(2):235-243.
42. Nieto-Pelegrin E., Martinez-Quiles N. Cell Commun. Signal. 2009, 7:11.
43. Williams K.C., Coppolino M.G. J. Cell Sci. 2014, 127(Pt 8):1712-1725.
44. Xiao K., McClatchy D.B., Shukla A.K., Zhao Y., Chen M., Shenoy S.K., Yates J.R., Lefkowitz R.J. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(29):12011-12016.
45. Szereszewski J.M., Pampillo M., Ahow M.R., Offermanns S., Bhattacharya M., Babwah A.V. PLoS One 2010, 5(9).
46. Kim B.M., Kim D.H., Park J.H., Surh Y.J., Na H.K. J. Cancer Prev. 2014, 19(1):23-30.
47. Yamaguchi H., Pixley F., Condeelis J. Eur. J. Cell Biol. 2006, 85(3-4):213-218.
48. Huang C., Ni Y., Wang T., Gao Y., Haudenschild C.C., Zhan X. J. Biol. Chem. 1997, 272(21):13911-13915.
49. Weed S.A., Karginov A.V., Schafer D.A., Weaver A.M., Kinley A.W., Cooper J.A., Parsons J.T. J. Cell Biol. 2000, 151(1):29-40.
50. Ge L., Ly Y., Hollenberg M., DeFea K. J. Biol. Chem. 2003, 278(36):34418-34426.
51. Zoudilova M., Min J., Richards H.L., Carter D., Huang T., DeFea K.A. J. Biol. Chem. 2010, 285(19):14318-14329.
52. Grass G.D., Tolliver L.B., Bratoeva M., Toole B.P. J. Biol. Chem. 2013, 288(36):26089-26104.
53. Gonzalez C. Endocrinology 2013, 154(6):1959-1961.